Review Articles (peer-reviewed)
| [R21] | Parr, M.K., Botrè, F., 2022. Supercritical fluid chromatography mass spectrometry as an emerging technique in doping control analysis. TrAC Trends in Analytical Chemistry, 116517 (doi: 10.1016/j.trac.2021.116517) |
| [R20] | Teubel J, Parr MK. Determination of Neurosteroids in Human Cerebrospinal Fluid in the 21st Century: a Review. J Steroid Biochem Mol Biol 204 (2020) 105753 (doi: 10.1016/j.jsbmb.2020.105753) |
| [R19] | Giacomello G, Scholten A, Parr MK. Current Methods for Stress Marker Detection in Saliva. J Pharm Biomed Anal 191 (2020) 113604 (doi: 10.1016/j.jpba.2020.113604 ) |
| [R18] | Joseph JF, Parr MK. Application of SFC for bioanalysis. In: Chowdhury S, Ma S. Identification and Quantification of Drugs, Metabolites, Drug Metabolizing Enzymes, and Transporters - Concepts, Methods, and Translational Sciences. Elsevier Amsterdam (2020) 151-183 (doi: 10.1016/B978-0-12-820018-6.00005-3) |
| [R17] | Harps LC, Joseph JF, Parr MK. SFC for chiral separations in bioanalysis. J Pharmaceut Biomed 162 (2019) 47–59 (doi: 10.1016/j.jpba.2018.08.061 ) |
| [R16] | Parr MK, Joseph JF. NDMA impurity in valsartan and other pharmaceutical products: Analytical methods for the determination of N-nitrosamines. J Pharmaceut Biomed 164 (2019) 536-549 (doi: 10.1016/j.jpba.2018.11.010) |
| [R15] | Parr MK, Müller-Schöll A. Pharmacology of doping agents – mechanisms promoting muscle hypertrophy. AIMS Molecular Science 5 (2018) 145-155(doi: 10.3934/molsci.2018.2.131) |
| [R14] | Parr MK, Schmidt AH. Life cycle management of analytical methods. J Pharmaceut Biomed 147 (2018) 506-517(doi: 10.1016/j.jpba.2017.06.020 ) |
|
[R13] |
Parr MK. Nahrungsergänzungsmittel und Sport. Ernährung Aktuell 3 (2017) 1-6 |
| [R12] | Parr MK, Schmidtsdorff S, Kollmeier AS. Nutritional supplements in sports - sense, nonsense or hazard?. Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz 60 (2017) 314-322 (doi: 10.1007/s00103-016-2498-1) |
| [R11] | Parr MK, Montacir O, Montacir H. Physicochemical characterization of biopharmaceuticals. J Pharmaceut Biomed 130 (2016) 366-389 (doi: 10.1016/j.jpba.2016.05.028 ) |
| [R10] | Liebetrau F, Parr MK. Determination of enantiomeric bioactives using new analytical SFC instruments. Chimica Oggi - Chemistry Today 33 (2015) 22-25 |
| [R9] | Parr MK, Joseph JF. Erlaubte Therapie oder Doping – Dos and Don’ts bei der Behandlung von Spitzensportlern. Journal für Anästhesie und Intensivbehandlung 22 (2015) 159-165 |
| [R8] | Joseph JF, Parr MK. Synthetic androgens as designer supplements. Current Neuropharmacology 13 (2015) 1-12 (doi:10.2174/1570159X13666141210224756) |
| [R7] | Parr MK, Schmidt AH. What is the potential of measuring the enantiomeric ratio of drugs using SFC-MS? Bioanalysis 6 (2014) 3267-3270 |
| [R6] | Parr MK. Leistungssteigerung durch Arzneimittelmissbrauch – Doping im Sport. Journal für Anästhesie und Intensivbehandlung 21 (2014) 139-144 |
| [R5] | Parr MK, Flenker U, Schänzer W. The assay of endogenous and exogenous anabolic androgenic steroids. In: Ghigo E, Lanfranco F, Strasburger CJ (eds). Hormone Use and Abuse by Athletes, Springer Science & Business Media LLC New York (2011) 121-130, ISBN 978-1-4419-7013-8 |
| [R4] | Parr MK, Schänzer W. Detection of the misuse of steroids in doping control. J Steroid Biochem Mol Biol 121 (2010) 528-537 |
| [R3] | Parr MK, Flenker U, Schänzer W. Sports related issues and biochemistry of natural and synthetic anabolic substances. Endocrinology and Metabolism Clinics of North America 39 (2010) 45-57 |
| [R2] | Parr MK, Opfermann G, Schänzer W. Analytical methods for the detection of clenbuterol. Bioanalysis 1 (2009) 437-450 |
| [R1] | Geyer H, Parr MK, Köhler K, Mareck U, Schänzer W, Thevis M. Nutritional supplements cross-contaminated and faked with doping substances. Journal of Mass Spectrometry 43 (2008) 892-902 |